Alzheimer's pathogenic mechanisms and underlying sex difference
- PMID: 33844047
- PMCID: PMC8720296
- DOI: 10.1007/s00018-021-03830-w
Alzheimer's pathogenic mechanisms and underlying sex difference
Abstract
AD is a neurodegenerative disease, and its frequency is often reported to be higher for women than men: almost two-thirds of patients with AD are women. One prevailing view is that women live longer than men on average of 4.5 years, plus there are more women aged 85 years or older than men in most global subpopulations; and older age is the greatest risk factor for AD. However, the differences in the actual risk of developing AD for men and women of the same age is difficult to assess, and the findings have been mixed. An increasing body of evidence from preclinical and clinical studies as well as the complications in estimating incidence support the sex-specific biological mechanisms in diverging AD risk as an important adjunct explanation to the epidemiologic perspective. Although some of the sex differences in AD prevalence are due to differences in longevity, other distinct biological mechanisms increase the risk and progression of AD in women. These risk factors include (1) deviations in brain structure and biomarkers, (2) psychosocial stress responses, (3) pregnancy, menopause, and sex hormones, (4) genetic background (i.e., APOE), (5) inflammation, gliosis, and immune module (i.e., TREM2), and (6) vascular disorders. More studies focusing on the underlying biological mechanisms for this phenomenon are needed to better understand AD. This review presents the most recent data in sex differences in AD-the gateway to precision medicine, therefore, shaping expert perspectives, inspiring researchers to go in new directions, and driving development of future diagnostic tools and treatments for AD in a more customized way.
Keywords: Aging; Cognition; Dementia; Estrogen; Gender difference; Hormones; Menopause.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Sexual dimorphism in predisposition to Alzheimer's disease.Neurobiol Aging. 2018 Oct;70:308-324. doi: 10.1016/j.neurobiolaging.2018.04.004. Epub 2018 Apr 17. Neurobiol Aging. 2018. PMID: 29754747 Free PMC article. Review.
-
Sex difference in Alzheimer's disease: An updated, balanced and emerging perspective on differing vulnerabilities.Handb Clin Neurol. 2020;175:261-273. doi: 10.1016/B978-0-444-64123-6.00018-7. Handb Clin Neurol. 2020. PMID: 33008530 Review.
-
Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.Mol Neurobiol. 2017 Oct;54(8):6471-6489. doi: 10.1007/s12035-016-0155-1. Epub 2016 Oct 11. Mol Neurobiol. 2017. PMID: 27730513
-
Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.Neuroscience. 2018 Mar 1;373:20-36. doi: 10.1016/j.neuroscience.2018.01.005. Epub 2018 Jan 11. Neuroscience. 2018. PMID: 29331531
-
Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.Front Neuroendocrinol. 2016 Oct;43:60-82. doi: 10.1016/j.yfrne.2016.09.001. Epub 2016 Sep 17. Front Neuroendocrinol. 2016. PMID: 27651175 Free PMC article. Review.
Cited by
-
Cognitive Performance and Incident Alzheimer's Dementia in Men Versus Women.J Prev Alzheimers Dis. 2024;11(1):162-170. doi: 10.14283/jpad.2023.90. J Prev Alzheimers Dis. 2024. PMID: 38230729 Free PMC article.
-
Hormone therapy is associated with lower Alzheimer's disease tau biomarkers in post-menopausal females -evidence from two independent cohorts.Alzheimers Res Ther. 2024 Jul 22;16(1):162. doi: 10.1186/s13195-024-01509-5. Alzheimers Res Ther. 2024. PMID: 39034389 Free PMC article.
-
Complexity of Sex Differences and Their Impact on Alzheimer's Disease.Biomedicines. 2023 Apr 24;11(5):1261. doi: 10.3390/biomedicines11051261. Biomedicines. 2023. PMID: 37238932 Free PMC article. Review.
-
Impaired muscle function, including its decline, is related to greater long-term late-life dementia risk in older women.J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1508-1519. doi: 10.1002/jcsm.13227. Epub 2023 Apr 19. J Cachexia Sarcopenia Muscle. 2023. PMID: 37073873 Free PMC article.
-
Sex-related differences in genetically determined Alzheimer's disease.Front Aging Neurosci. 2025 Mar 4;17:1522434. doi: 10.3389/fnagi.2025.1522434. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40103931 Free PMC article. Review.
References
-
- Alzheimer’s disease facts and figures (2020) Alzheimers Dement 16(3):391–460
Publication types
MeSH terms
Substances
Grants and funding
- R21 AG066090/AG/NIA NIH HHS/United States
- R03AG063287/AG/NIA NIH HHS/United States
- R21AG066090/AG/NIA NIH HHS/United States
- R01AG064798/AG/NIA NIH HHS/United States
- RF1 NS122060/NS/NINDS NIH HHS/United States
- R01 AG064798/AG/NIA NIH HHS/United States
- R01 NS110687/NS/NINDS NIH HHS/United States
- R01HL140562/HL/NHLBI NIH HHS/United States
- R01 HL140562/HL/NHLBI NIH HHS/United States
- R01 AG061288/AG/NIA NIH HHS/United States
- R01AG061288/AG/NIA NIH HHS/United States
- R03 AG063287/AG/NIA NIH HHS/United States
- R01NS110687/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous